Composition
- Active ingredients
- ESTROPIPATE 0.75MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ESTROPIPATE 3MG · TabletANDA040296-003 · Discontinued
- ESTROPIPATE 0.75MG · TabletANDA040296-001 · Discontinued
- ESTROPIPATE 1.5MG · TabletANDA040296-002 · Discontinued
- ESTROPIPATE 1.5MG · TabletANDA040135-002 · Discontinued
- ESTROPIPATE 3MG · TabletANDA040135-003 · Discontinued
- ESTROPIPATE 0.75MG · TabletANDA040135-001 · Discontinued
- ESTROPIPATE 0.75MG · TabletThis page
- ESTROPIPATE 1.5MG · TabletANDA081214-001 · Discontinued
- ESTROPIPATE 3MG · TabletANDA081215-001 · Discontinued
- ESTROPIPATE 3MG · TabletANDA040359-003 · Discontinued
- ESTROPIPATE 0.75MG · TabletANDA040359-001 · Discontinued
- ESTROPIPATE 1.5MG · TabletANDA040359-002 · Discontinued
- ESTROPIPATE 6MG · TabletANDA081216-001 · Discontinued
At a glance
- Brand name
- Estropipate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Watson Labs
- Status
- Discontinued
- FDA approval
- 23 Sept 1993
- Application
- ANDA081213-001